NW Metastatic Breast Cancer Conference Returns

View Full Press Release (PDF)

SEATTLE – The fourth annual gathering of researchers, patients, advocates and healthcare providers is scheduled for Saturday, September 7th at the Amazon Meeting Center in Seattle, Washington. This conference, streamed live, through a generous partnership between Amazon Web Services, Pfizer, Swedish Cancer Institute, Seattle Cancer Care Alliance, Seattle Genetics, and Komen Puget Sound, is a full day of information on treatments, clinical trials, patient support and other issues facing those with stage IV/metastatic breast cancer (MBC). The conference brings together the top local and national researchers and clinicians from organizations including Fred Hutch, SCCA, Swedish, Virginia Mason and NCI to speak to and help MBC patients..

Dr. Larissa Korde, noted oncologist and head of the Breast Cancer Therapeutics, Clinical Investigations Branch at the National Cancer Institute, who has run several breast cancer-focused clinical trials will be attending the conference. She has also written papers on addressing the attitudes and practices of health factors (diet, physical activity, and weight management) in patients with cancer as well as papers on immunotherapy and hormone receptor status in breast cancer patients.

New this year is the clinical trials fair that will allow patients to connect directly with organizations running clinical trials for metastatic disease. The fair presents a unique opportunity for patients to learn more about available clinical trials.

Metastatic breast cancer is an advanced stage of breast cancer where tumor cells have spread to other parts of the body, such as the bones, liver, lungs or brain. In the 1970s, only 10 percent of patients survived five years after a MBC diagnosis. Today, due to research and the discovery of new and more effective treatments, this has increased to an average of 25 percent. Komen is dedicated to understanding why metastasis occurs and how to stop it, with more than two-thirds of our FY18 research grants addressing MBC.

When asked about the impact of the conference, Teri Pollastro, conference co-chair and patient advocate said, “Knowledge is power. The NW Metastatic Breast Cancer Conference provides knowledge to patients so they can regain power over their lives.”

This year’s conference includes sessions on immunotherapy, precision medicine, and understanding research from bench to clinic as well as breakout sessions focused on metastatic breast cancer subtype and location.

Saturday, September 7th | 7:30am – 6:30pm
Amazon Meeting Center
2031 7th Avenue, Seattle, WA 98121
Attendance is free, but registration is required.
https://komenpugetsound.org/nwmbcc

About Susan G. Komen ® Puget Sound
Komen Puget Sound was founded by local volunteers in 1993. Through the community’s generosity, Komen Puget Sound has given more than $33 million to fund breast cancer screenings, patient support and medical research to prevent and cure, helping tens of thousands of local, low-income women receive services critical to early detection and survival. To learn more about Komen Puget Sound, please visit www.komenpugetsound.org or follow us on Facebook (facebook.com/KomenPugetSound), Twitter (@KomenPugetSound) or Instagram (instagram.com/komenpugetsound).

# # # #